DK546186D0 - Substituerede benzylethere, deres fremstilling og anvendelse - Google Patents

Substituerede benzylethere, deres fremstilling og anvendelse

Info

Publication number
DK546186D0
DK546186D0 DK546186A DK546186A DK546186D0 DK 546186 D0 DK546186 D0 DK 546186D0 DK 546186 A DK546186 A DK 546186A DK 546186 A DK546186 A DK 546186A DK 546186 D0 DK546186 D0 DK 546186D0
Authority
DK
Denmark
Prior art keywords
benzylethers
substituted
preparation
substituted benzylethers
Prior art date
Application number
DK546186A
Other languages
English (en)
Other versions
DK546186A (da
Inventor
Klaus-Helmut Mohrs
Romanis Fruchtmann
Christian Kohlsdorfer
Original Assignee
Bayer Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Ag filed Critical Bayer Ag
Publication of DK546186D0 publication Critical patent/DK546186D0/da
Publication of DK546186A publication Critical patent/DK546186A/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/20—Oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/60—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings condensed with carbocyclic rings or ring systems
    • C07D277/62—Benzothiazoles
    • C07D277/68—Benzothiazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
    • C07D277/70—Sulfur atoms
    • C07D277/76—Sulfur atoms attached to a second hetero atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/20—Oxygen atoms
    • C07D215/24—Oxygen atoms attached in position 8
    • C07D215/26—Alcohols; Ethers thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/20—Oxygen atoms
    • C07D215/24—Oxygen atoms attached in position 8
    • C07D215/26—Alcohols; Ethers thereof
    • C07D215/28—Alcohols; Ethers thereof with halogen atoms or nitro radicals in positions 5, 6 or 7
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/36—Sulfur atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/38—Nitrogen atoms
    • C07D215/40—Nitrogen atoms attached in position 8
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/58—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems with hetero atoms directly attached to the ring nitrogen atom
    • C07D215/60—N-oxides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D217/00—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
    • C07D217/02—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with only hydrogen atoms or radicals containing only carbon and hydrogen atoms, directly attached to carbon atoms of the nitrogen-containing ring; Alkylene-bis-isoquinolines
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/60—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings condensed with carbocyclic rings or ring systems
    • C07D277/62—Benzothiazoles
    • C07D277/64—Benzothiazoles with only hydrocarbon or substituted hydrocarbon radicals attached in position 2

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Indole Compounds (AREA)
DK546186A 1985-11-16 1986-11-14 Substituerede benzylethere, deres fremstilling og anvendelse DK546186A (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE3540743 1985-11-16
DE19863617183 DE3617183A1 (de) 1985-11-16 1986-05-22 Substituierte benzylether

Publications (2)

Publication Number Publication Date
DK546186D0 true DK546186D0 (da) 1986-11-14
DK546186A DK546186A (da) 1987-05-17

Family

ID=25837950

Family Applications (1)

Application Number Title Priority Date Filing Date
DK546186A DK546186A (da) 1985-11-16 1986-11-14 Substituerede benzylethere, deres fremstilling og anvendelse

Country Status (10)

Country Link
US (1) US5006534A (da)
EP (1) EP0224086B1 (da)
KR (1) KR870004961A (da)
AU (1) AU590024B2 (da)
DE (2) DE3617183A1 (da)
DK (1) DK546186A (da)
ES (1) ES2020919B3 (da)
FI (1) FI864620L (da)
HU (1) HU196757B (da)
IL (1) IL80624A (da)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5078906A (en) * 1989-01-27 1992-01-07 Mine Safety Appliances Company Strong base reagent
US5202326A (en) * 1989-02-28 1993-04-13 Imperial Chemical Industries Plc Heterocyclic ethers
IL93343A0 (en) * 1989-02-28 1990-11-29 Ici Plc Heterocyclic cycloalkanes
US5217977A (en) * 1989-02-28 1993-06-08 Imperial Chemical Industries Plc Heterocyclic cycloalkanes
US5140047A (en) * 1991-05-03 1992-08-18 Smithkline Beecham Corporation Lipoxygenase inhibitors
US5334600A (en) * 1991-07-30 1994-08-02 Ciba-Geigy Corporation Isoquinolyl substituted hydroxylamine derivatives
US5260316A (en) * 1991-07-30 1993-11-09 Ciba-Geigy Corporation Isoquinolyl substituted hydroxylamine derivatives
US5350761A (en) * 1991-07-30 1994-09-27 Ciba-Geigy Corporation Indolyl substituted hydroxylamine derivatives
EP0555067A1 (en) * 1992-02-07 1993-08-11 Zeneca Limited Hydroxylamine derivatives as 5-lipoxygenase inhibitors
GB9300894D0 (en) * 1992-02-07 1993-03-10 Zeneca Ltd Oxime derivatives
FR2689889B1 (fr) * 1992-04-10 1994-06-10 Rhone Poulenc Rorer Sa Nouveaux derives de perhydroisoindole, et leur preparation.
CA2094465A1 (en) * 1992-04-23 1993-10-24 Pierre Andre Raymond Bruneau Cycloalkane derivatives
CA2095006A1 (en) * 1992-05-12 1993-11-13 Philip Neil Edwards Oxime derivatives
CA2095005A1 (en) * 1992-05-12 1993-11-13 Philip Neil Edwards Hydroxylamine derivatives
WO1994022846A1 (en) * 1993-03-30 1994-10-13 Pfizer Inc. Compounds enhancing antitumor activity of other cytotoxic agents
AU680870B2 (en) * 1993-04-28 1997-08-14 Astellas Pharma Inc. New heterocyclic compounds
US5410054A (en) * 1993-07-20 1995-04-25 Merck Frosst Canada, Inc. Heteroaryl quinolines as inhibitors of leukotriene biosynthesis
WO1996013485A1 (en) * 1994-10-27 1996-05-09 Fujisawa Pharmaceutical Co., Ltd. Pyridopyrimidones, quinolines and fused n-heretocycles as bradykinin antagonists
US6130217A (en) * 1995-09-20 2000-10-10 Pfizer Inc Compounds enhancing antitumor activity of other cytotoxic agents
AUPN952696A0 (en) * 1996-04-29 1996-05-23 Fujisawa Pharmaceutical Co., Ltd. New heterocyclic compounds
FR2751650B1 (fr) * 1996-07-24 1998-10-09 Fournier Ind & Sante Nouveaux composes de n-benzenesulfonyl-l-proline, procede de preparation et utilisation en therapeutique
FR2756562B1 (fr) * 1996-12-04 1999-01-08 Fournier Ind & Sante Nouveaux composes de n-benzenesulfonyl-l-proline, procede de preparation et utilisation en therapeutique
FR2790260B1 (fr) 1999-02-26 2001-05-04 Fournier Ind & Sante Nouveaux composes de n-(benzenesulfonamide), procede de preparation et utilisation en therapeutique

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2455858A1 (de) * 1973-12-06 1975-06-12 Sandoz Ag Neue acyl-substituierte benzyl- und dibenzylaether und verfahren zu deren herstellung
AU541697B2 (en) * 1979-11-19 1985-01-17 Ici Australia Limited Quinoline derivatives
US4360700A (en) * 1981-11-02 1982-11-23 Pfizer Inc. Intermediates for making 1-(3-benzyloxyphenyl)-1,1-dimethylheptane
IE56702B1 (en) * 1982-12-01 1991-11-06 Usv Pharma Corp Antiinflammatory antiallergic compounds
US4794188A (en) * 1982-12-01 1988-12-27 Usv Pharmaceutical Corporation Certain unsymmetrical quinolinyl ethers having anti-inflammatory and anti-allergic activity
HU186654B (en) * 1982-12-28 1985-09-30 Richter Gedeon Vegyeszet Process for producing new pyridine derivatives, acid additional salts and quaternary salts and pharmaceutical compositions containing them
JPS59210021A (ja) * 1983-05-12 1984-11-28 Kyowa Hakko Kogyo Co Ltd リポキシゲナ−ゼ代謝産物に起因する疾患の予防治療剤
DE3337044A1 (de) * 1983-10-12 1985-04-25 Basf Ag, 6700 Ludwigshafen Phenoxyfettsaeurederivate, verfahren zu ihrer herstellung und ihre verwendung zur bekaempfung unerwuenschten pflanzenwachstums
NO174506B (no) * 1984-10-30 1994-02-07 Usv Pharma Corp Analogifremgangsmaate ved fremstilling av terapeutisk aktive forbindelser
US4625034A (en) * 1985-02-04 1986-11-25 Usv Pharmaceutical Corp. 1,2-Dihydro; 1,2,3,4-tetrahydro; 5,8 dihydro; and 5,6,7,8-tetrahydroquinoline derivatives
US4631287A (en) * 1985-04-16 1986-12-23 Usv Pharmaceutical Corp. Aryl and heteroaryl ethers as agents for the treatment of hypersensitive ailments
US4661499A (en) * 1985-06-18 1987-04-28 Merck Frosst Canada, Inc. 2-[(substituted)-phenoxymethyl]quinolines

Also Published As

Publication number Publication date
EP0224086B1 (de) 1990-10-24
FI864620A7 (fi) 1987-05-17
IL80624A (en) 1990-12-23
IL80624A0 (en) 1987-02-27
HUT44512A (en) 1988-03-28
HU196757B (en) 1989-01-30
FI864620L (fi) 1987-05-17
ES2020919B3 (es) 1991-10-16
US5006534A (en) 1991-04-09
EP0224086A2 (de) 1987-06-03
DE3617183A1 (de) 1987-05-27
KR870004961A (ko) 1987-06-02
DE3675161D1 (de) 1990-11-29
FI864620A0 (fi) 1986-11-13
AU590024B2 (en) 1989-10-26
AU6537586A (en) 1987-05-21
DK546186A (da) 1987-05-17
EP0224086A3 (en) 1988-10-19

Similar Documents

Publication Publication Date Title
DK617686A (da) 3-amino-4,5-dihydroxypiperidiner, deres fremstilling og anvendelse
DK546186A (da) Substituerede benzylethere, deres fremstilling og anvendelse
DK129386D0 (da) Iodpropargylethere, deres fremstilling og anvendelse
DK543386A (da) Thienooxazinoner deres fremstilling og anvendelse
DK354687A (da) 7-acyloxy-6-aminoacyloxypolyoxylabdaner, deres fremstilling og anvendelse
DK519586A (da) 1-aryl-4-nitro-pyrazoler, deres fremstilling og anvendelse
DK28685D0 (da) Azolyl-aryl-alkanol-derivater, deres fremstilling og anvendelse
DK401586A (da) Substituerede toluidiner, deres fremstilling og anvendelse
DK380286A (da) Sulfonamider, deres fremstilling og anvendelse
DK396886D0 (da) Gem-dihalogen-1,8-diamino-4-azaoctaner, deres fremstilling og anvendelse
DK617886D0 (da) 1-aryl-pyrazoler, deres fremstilling og anvendelse
DK548586D0 (da) Thienylsulfonylguanidin-derivater, deres fremstilling og anvendelse
DK212687D0 (da) Benzothiazinon-derivater, deres fremstilling og anvendelse
DK377786D0 (da) 1-aryl-5-hydrazino-pyrazoler, deres fremstilling og anvendelse
DK675687A (da) Substituerede n-methylisoxazolidiner, deres fremstilling og anvendelse
DK136985D0 (da) Sulfamoylguanidin-derivater, deres fremstilling og anvendelse
DK625287D0 (da) 1-aryloxy-3-amino-2-propanoler, deres fremstilling og anvendelse
DK538586D0 (da) Substituerede pyrazolin-5-oner, deres fremstilling og anvendelse
DK126987A (da) Pyrimidoindoler, deres fremstilling og anvendelse
DK393986A (da) Lactamamider, deres fremstilling og anvendelse
DK136885A (da) Thiatriazin-derivater, deres fremstilling og anvendelse
DK451486D0 (da) Alkenylazoler, deres fremstilling og anvendelse
DK540786D0 (da) 2-hydroxybenzamider, deres fremstilling og anvendelse
DK564986D0 (da) Thienylurinstofderivater, deres fremstilling og anvendelse
DK136785D0 (da) Thiatriazin-derivater, deres fremstilling og anvendelse

Legal Events

Date Code Title Description
ATS Application withdrawn